2002
DOI: 10.2214/ajr.179.4.1790825
|View full text |Cite
|
Sign up to set email alerts
|

Screening for Preclinical Disease: Test and Disease Characteristics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
66
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 97 publications
(68 citation statements)
references
References 35 publications
2
66
0
Order By: Relevance
“…The ability of a measure to case-find or 'rule in' dementia with minimal false negatives is its positive predictive value (PPV), and the ability of a measure to screen or 'rule out' a diagnosis with minimal false positives is its negative predictive value (NPV) [9,79] . The PPV and NPV are considered most relevant for clinicians [80] .…”
Section: Measures Of Predictive Validity For Dementia Versus Nondementiamentioning
confidence: 99%
See 3 more Smart Citations
“…The ability of a measure to case-find or 'rule in' dementia with minimal false negatives is its positive predictive value (PPV), and the ability of a measure to screen or 'rule out' a diagnosis with minimal false positives is its negative predictive value (NPV) [9,79] . The PPV and NPV are considered most relevant for clinicians [80] .…”
Section: Measures Of Predictive Validity For Dementia Versus Nondementiamentioning
confidence: 99%
“…Combining measures in parallel or sequentially can address the challenges of the 'tradeoff' between sensitivity and specificity [9,80,84] . The SMCC (a single-domain measure) and the MMSE (a multidomain measure) were combined in 4 different ways and tested for improvements in accuracy of screening for dementia compared to the use of the MMSE or SMCC alone ( table 4 ).…”
Section: Combining Screening Measuresmentioning
confidence: 99%
See 2 more Smart Citations
“…The 2 major objectives of a good screening program are: (1) detection of disease at a stage when treatment can be more effective than it would be after the patient develops signs and symptoms, and (2) identification of risk factors that increase the likelihood of developing the disease and use of this knowledge to prevent or lessen the disease by modifying the risk factors [2]. To fulfill these objectives, a screening test and the disease it screens for must meet the following criteria.…”
mentioning
confidence: 99%